Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Sirolimus by Palvella Therapeutics for Lymphoproliferative Disorders: Likelihood of Approval
Sirolimus is under clinical development by Palvella Therapeutics and currently in Phase III for Lymphoproliferative Disorders. According to GlobalData, Phase...
Sirolimus by Biodexa Pharmaceuticals for Prostate Cancer: Likelihood of Approval
Sirolimus is under clinical development by Biodexa Pharmaceuticals and currently in Phase II for Prostate Cancer. According to GlobalData, Phase...
Sirolimus by Biodexa Pharmaceuticals for Familial Adenomatous Polyposis: Likelihood of Approval
Sirolimus is under clinical development by Biodexa Pharmaceuticals and currently in Phase II for Familial Adenomatous Polyposis. According to GlobalData,...
Sirolimus by Palvella Therapeutics for Lymphoproliferative Disorders: Likelihood of Approval
Sirolimus is under clinical development by Palvella Therapeutics and currently in Phase II for Lymphoproliferative Disorders. According to GlobalData, Phase...
Sirolimus by Pfizer for Growth Disorders: Likelihood of Approval
Sirolimus is under clinical development by Pfizer and currently in Phase II for Growth Disorders. According to GlobalData, Phase II...